Genomic Health Reports 8 Percent Jump in Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health's revenues for the first quarter increased 8 percent to $63.1 million from $58.5 million year over year, driven by increased use of its Oncotype DX products and significant growth in the use of its tests in markets outside of the US, the firm reported after the close of the market Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.